Table 2.
Baseline and change in level of risk factors in individuals with and without worsened kidney function
Cases | Controls | p value | |
---|---|---|---|
Baseline levels | |||
CRP, mg/l1 | 2.9 (1.6 to 7.5) | 2.6 (1.4 to 4.6) | 0.06 |
IL-6, pg/l1 | 2.2 (1.3 to 3.2) | 1.8 (1.2 to 2.8) | 0.01 |
Fibrinogen, mg/dl | 336 ± 73 | 317 ± 66 | 0.007 |
Factor VII, % | 130 ± 35 | 125 ± 28 | 0.07 |
Factor VIII, % | 132 ± 42 | 125 ± 39 | 0.10 |
HDL, mg/dl | 50 ± 15 | 53 ± 16 | 0.04 |
LDL, mg/dl | 127 ± 37 | 129 ± 36 | 0.51 |
Triglycerides, mg/dl | 163 ± 100 | 143 ± 74 | 0.02 |
Change in risk factors | |||
CRP, mg/l1 | +0.2 (−0.9 to 2.6) | +0.2 (−0.8 to 1.8) | 0.65 |
IL-6, pg/l1 | +1.5 (0.2 to 3.2) | +0.9 (0.2 to 1.9) | 0.03 |
Fibrinogen, mg/dl | +23 ± 85 | +10 ± 57 | 0.06 |
Factor VII, % | −16 ± 29 | −16 ± 19 | 0.91 |
Factor VIII, % | +60 ± 54 | +44 ± 46 | 0.003 |
HDL, mg/dl | −2 ± 8 | −1 ± 7 | 0.31 |
LDL, mg/dl | −3 ± 31 | −3 ± 22 | 0.98 |
Triglycerides, mg/dl | +10 ± 94 | −3 ± 62 | 0.12 |
Median, interquartile range.